advertisement
Journal of Ocular Pharmacology and Therapeutics 33
Showing records 1 to 25 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics81442 Inhibition of Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing Signaling
Wen J
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 331-340
80473 Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma
Tekin S
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 216-222
80694 Patient-Reported Nonadherence with Glaucoma Therapy
Wolfram C
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 223-228
80749 Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma
Brown GC
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 145-160
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80603 GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure
Itakura T; Webster A
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 203-215
80694 Patient-Reported Nonadherence with Glaucoma Therapy
Stahlberg E
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 223-228
81442 Inhibition of Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing Signaling
Lin X
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 331-340
80473 Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma
Seven E
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 216-222
80749 Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma
Brown MM
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 145-160
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Wang JW; Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80473 Evaluation of Antiglaucomatous Drops on Conjunctival Thickness in Patients with Primary Open-Angle Glaucoma
Batur M
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 216-222
81442 Inhibition of Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing Signaling
Gao W
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 331-340
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80694 Patient-Reported Nonadherence with Glaucoma Therapy
Pfeiffer N
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 223-228
80603 GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure
Chintala SK
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 203-215
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80603 GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure
Wang Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 203-215
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
81442 Inhibition of Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing Signaling
Qu B
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 331-340
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
81442 Inhibition of Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing Signaling
Zuo Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 331-340
80603 GPR158 in the Visual System: Homeostatic Role in Regulation of Intraocular Pressure
Gonzalez JM
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 203-215
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
81442 Inhibition of Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing Signaling
Liu R
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 331-340
